|
Volumn 146, Issue 1-2, 2009, Pages 3-4
|
Is it possible to develop an animal model of fibromyalgia?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
BIOGENIC AMINE;
DOPAMINE;
GLUTAMIC ACID;
NORADRENALIN;
PROTEIN FOS;
RESERPINE;
SEROTONIN;
SEROTONIN RECEPTOR;
SUBSTANCE P;
ANXIETY DISORDER;
BRAIN STEM;
CENTRAL NERVOUS SYSTEM;
DEPRESSION;
EDITORIAL;
FACILITATION;
FATIGUE;
FIBROMYALGIA;
HUMAN;
HYPERALGESIA;
HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM;
MOTONEURON;
NERVE CELL EXCITABILITY;
NEUROMODULATION;
NONHUMAN;
PERIPHERAL NERVOUS SYSTEM;
PRIORITY JOURNAL;
SEROTONIN RELEASE;
SEROTONINERGIC SYSTEM;
SLEEP DISORDER;
SPINAL CORD;
SPINAL CORD DORSAL HORN;
SYMPTOMATOLOGY;
ADRENERGIC UPTAKE INHIBITORS;
ANIMALS;
BIOGENIC AMINES;
DISEASE MODELS, ANIMAL;
FIBROMYALGIA;
HUMANS;
NEUROTRANSMITTER AGENTS;
RESERPINE;
|
EID: 70349767927
PISSN: 03043959
EISSN: None
Source Type: Journal
DOI: 10.1016/j.pain.2009.07.032 Document Type: Editorial |
Times cited : (13)
|
References (10)
|